Skip to main content
SpringerLink
Log in

Prevalence and Clinical Characteristics of Acute Myeloid Leukemia Associated with Disseminated Intravascular Coagulation

  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Disseminated intravascular coagulation (DIC) is one of the important complications to develop in patients with acute myeloid leukemia (AML). While acute promyelocytic leukemia (APL) is a strong risk factor for DIC, other clinical features have not been fully defined. We retrospectively analyzed 161 consecutive adult patients with de novo non-APL AML. DIC was diagnosed in 52 patients (32%); 28 patients at diagnosis and 24 soon after the initiation of induction chemotherapy. Leukocyte counts, C-reactive protein, and lactate dehydrogenase were significantly higher in the DIC+ group. Negative expressions of CD13, CD19, CD34, and HLA-DR were more prevalent in the DIC+ group. On multivariate logistic-regression analysis, variables that were independently associated with the development of DIC were high C-reactive protein, high leukocyte count, negative expressions of CD13 and HLA-DR, and cytogenetics with a normal karyotype or 11q23 abnormality. Although DIC is considered to be associated with serious morbidity and occasional mortality, we did not find any significant differences in the complete remission rate, overall or disease-free survival between DIC+ and DIC- groups. This study is the first to define the clinical characteristics associated with DIC in patients with non-APL AML, but exactly how and when DIC should be treated remains to be determined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Weltermann A, Pabinger I, Geissler K, et al. Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis.Leukemia. 1998;12:1182–1186.

    Article  PubMed  CAS  Google Scholar 

  2. Nur S, Anwar M, Saleem M, Ahmad PA. Disseminated intravascular coagulation in acute leukaemias at first diagnosis.Eur J Haematol. 1995;55:78–82.

    Article  PubMed  CAS  Google Scholar 

  3. Jagasia MH, Arrowsmith ER. Complications of Hematopoietic Neoplasms. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B, eds.Wintrobe’s Clinical Hematology. 11th edition. Lippincott Williams & Wilkins; 2004:1921–1943.

  4. Avvisati G, Lo Coco F, Diverio D, et al. AIDA(All-trans retinoic acid + Idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne del- l’Adulto (GIMEMA) pilot study.Blood. 1996;88:1390–1398.

    PubMed  CAS  Google Scholar 

  5. Burnett AK, Grimwade D, Solomon E, Wheatley K, Goldstone AH. Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated withall-trans retinoic acid: result of the randomized MRC trial.Blood. 1999;93:4131–4143.

    PubMed  CAS  Google Scholar 

  6. Fenaux P, Chastang C, Chevret S, et al. A randomized comparison of alltrans retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia.Blood. 1999;94:1192–1200.

    PubMed  CAS  Google Scholar 

  7. Kobayashi N, Maegawa K, Takada M, Tanaka H, Gonmori H. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan.Bibl Haematol. 1987;49:265–275.

    Google Scholar 

  8. Wada H, Gabazza EC, Asakura H, et al. Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Hemostasis (ISTH) and of the Japanese Ministry of Health and Welfare for Overt DIC.Am J Hematol. 2003;74:17–22.

    Article  PubMed  Google Scholar 

  9. Grimwade D, Howe K, Langabeer S, et al. Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial.Br J Haematol. 1996;94:557.

    PubMed  CAS  Google Scholar 

  10. Taylor FB Jr, Toh CH, Hoots K, Wada H, Levi M. Towards a definition, clinical and laboratory criteria and a scoring system for disseminated intravascular coagulation.Thromb Haemost. 2001;86:1327–1330.

    Article  PubMed  CAS  Google Scholar 

  11. Higuchi T, Toyama D, Hirota Y, et al. Disseminated intravascular coagulation complicating acute lymphoblastic leukemia: a study of childhood and adult cases.Leuk Lymphoma. 2005;46:1169–1176.

    Article  PubMed  Google Scholar 

  12. Bunin NJ. Pui CH: Differing complications of hyperleukocytosis in children with acute lymphoblastic or acute nonlymphoblastic leukemia.J Clin Oncol. 1985;3:1590–1595.

    Article  PubMed  CAS  Google Scholar 

  13. Franco, RF, de Jonge, E, Dekkers, PE, et al. The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation.Blood. 2000;96:554–559.

    PubMed  CAS  Google Scholar 

  14. Sase T, Wada H, Nishioka J, et al. Measurement of tissue factor messenger RNA levels in leukocytes from patients in hypercoagu- lable state caused by several underlying diseases.Thromb Haemost. 2003;89:660–665.

    Article  PubMed  CAS  Google Scholar 

  15. Dennis MW, Downey C, Brufatto N, Nesheim ME, Stevenson K, Toh CH. Prothrombinase enhancement through quantitative and qualitative changes affecting very low density lipoprotein In complex with C-reactive protein.Thromb Haemost. 2004;91(3):522–530.

    Article  PubMed  CAS  Google Scholar 

  16. Brunning RD, Matutes E, Flandrin G, et al. Acute myeloid leukemia with recurrent genetic abnormalities. In: Jaffe ES, ed.Pathology and Genetics. Tumours of Hematopoietic and Lymphoid Tissues (World Health Organization Classification of Tumours). IRAC Press, Lyon, 2001:81–87.

    Google Scholar 

  17. Kaleem Z, Crawford E, Pathan MH, et al. Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data.Arch Pathol Lab Med. 2003;127:42–48.

    PubMed  Google Scholar 

  18. Wetzler M, McElwain BK, Stewart CC, et al. HLA-DR antigen- negative acute myeloid leukemia.Leukemia. 2003;17:707–715.

    Article  PubMed  CAS  Google Scholar 

  19. Muroi K, Yoshida M, Suzuki T, et al. Clinicopathological features in HLA-DR-negative acute myeloid leukemia.Rinsho Ketsueki. 1997;38:631–637.

    PubMed  CAS  Google Scholar 

  20. Kaleem Z, Crawford E, Pathan MH, et al. Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data.Arch Pathol Lab Med. 2003;127:42–48.

    PubMed  Google Scholar 

  21. Sarris AH, Kempin S, Berman E, et al. High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia.Blood. 1992;79:1305–1310.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Showa-machi 3-39-15, 371-8511, Maebashi, Gunma, Japan

    Hideki Uchiumi, Takafumi Matsushima, Hiroyuki Irisawa, Takayuki Saitoh, Norifumi Tsukamoto & Yoshihisa Nojima

  2. Division of Blood Transfusion Service, Gunma University Hospital, Gunma, Japan

    Arito Yamane & Masamitsu Karasawa

  3. Saiseikai Maebashi Hospital, Maebashi, Japan

    Noriko Doki, Tohru Sakura & Shuichi Miyawaki

  4. Fujioka General Hospital, Gunma, Japan

    Takahiro Jimbo

  5. School of Health Sciences Faculty of Medicine, Gunma University, Gunma, Japan

    Hiroshi Handa & Hirokazu Murakami

Authors
  1. Hideki Uchiumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takafumi Matsushima
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arito Yamane
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Noriko Doki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroyuki Irisawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takayuki Saitoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tohru Sakura
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Takahiro Jimbo
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hiroshi Handa
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Norifumi Tsukamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Masamitsu Karasawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Shuichi Miyawaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Hirokazu Murakami
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Yoshihisa Nojima
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hideki Uchiumi.

About this article

Cite this article

Uchiumi, H., Matsushima, T., Yamane, A. et al. Prevalence and Clinical Characteristics of Acute Myeloid Leukemia Associated with Disseminated Intravascular Coagulation. Int J Hematol 86, 137–142 (2007). https://doi.org/10.1532/IJH97.06173

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1532/IJH97.06173

Key words

Search

Navigation